Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
The role of transcriptional corepressor ZMYM2 in neurodevelopment
EF 2023-24
Résumé
ZMYM2 is a gene which is required for normal embryonic development. Mutations in ZMYM2 can cause congenital anomalies of multiple organ systems, including renal, cardiac, and neurological abnormalities, as well as neurodevelopmental disorders such as autism, intellectual disability, and schizophrenia. However, the molecular role of ZMYM2 in neurodevelopment is unknown. ZMYM2 codes for a protein which helps other proteins “turn off” specific genes during development. Without ZMYM2, genes that are normally silenced can become active and disrupt normal development. We hypothesize that ZMYM2 plays an essential role in neurodevelopment by helping to silence certain genes in neural tissues. Our lab has generated some of the first mutant mice and mouse stem cells with mutations in Zmym2, the mouse equivalent to human ZMYM2. We will use these models to study ZMYM2 in neurodevelopment. First, we will study ZMYM2 mutations in neural progenitors, which are cells that give rise to the nervous system. We will grow mouse and human neural progenitors in the lab and use molecular biology and bioinformatics tools to compare ZMYM2 mutants to normal cells. We will look for target genes that are turned on inappropriately in the mutant cells and identify proteins that work with ZMYM2 to silence them. We will also study how ZMYM2 affects neurodevelopment in genetically engineered mice which have Zmym2 mutations in neural cells. We will identify brain structure defects in the Zmym2 mutant mice, determine when they are first observed, and test whether they show the same molecular trends as neural progenitors. Our work will shed light on the mechanisms underlying neurodevelopmental disorders associated with ZMYM2 mutations and help improve treatments and diagnoses for patients in the future.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506414
Name
Nie Chu Han
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of transcriptional corepressor ZMYM2 in neurodevelopment
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Congenital Anomalies; Epigenetics; Gene Regulation; Genetics; Genomics; Mouse Model; Neurodevelopment; Proteomics; Stem Cells; Transcriptional Repression
Abstract
ZMYM2 is a gene which is required for normal embryonic development. Mutations in ZMYM2 can cause congenital anomalies of multiple organ systems, including renal, cardiac, and neurological abnormalities, as well as neurodevelopmental disorders such as autism, intellectual disability, and schizophrenia. However, the molecular role of ZMYM2 in neurodevelopment is unknown. ZMYM2 codes for a protein which helps other proteins “turn off” specific genes during development. Without ZMYM2, genes that are normally silenced can become active and disrupt normal development. We hypothesize that ZMYM2 plays an essential role in neurodevelopment by helping to silence certain genes in neural tissues. Our lab has generated some of the first mutant mice and mouse stem cells with mutations in Zmym2, the mouse equivalent to human ZMYM2. We will use these models to study ZMYM2 in neurodevelopment. First, we will study ZMYM2 mutations in neural progenitors, which are cells that give rise to the nervous system. We will grow mouse and human neural progenitors in the lab and use molecular biology and bioinformatics tools to compare ZMYM2 mutants to normal cells. We will look for target genes that are turned on inappropriately in the mutant cells and identify proteins that work with ZMYM2 to silence them. We will also study how ZMYM2 affects neurodevelopment in genetically engineered mice which have Zmym2 mutations in neural cells. We will identify brain structure defects in the Zmym2 mutant mice, determine when they are first observed, and test whether they show the same molecular trends as neural progenitors. Our work will shed light on the mechanisms underlying neurodevelopmental disorders associated with ZMYM2 mutations and help improve treatments and diagnoses for patients in the future.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nie, Chu Han
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~